Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
Hepatol Res. 2009 Jan;39(1):1-6. doi: 10.1111/j.1872-034X.2008.00400.x. Epub 2008 Jul 4.
Drug-induced liver injury is an major cause of acute liver injury and the incidence of drug-induced liver injury seems to be increasing with an increase in the number of new drugs available. The diagnostic scale of drug-induced liver injury was been modified by the International Consensus Meeting during Digestive Disease Week, Japan 2004, which includes the score of the drug-lymphocyte stimulation test and eosinophilia. Although the modified diagnostic scale is useful, and widely used in Japan, there will be many issues to be investigated in the future. According to a recent survey of drug-induced liver injury cases in Japan, drug-induced liver injury from dietary supplements are increasing, as has been observed in foreign countries. More research is needed to elucidate the mechanisms of drug metabolism and the pathophysiology of liver injury by various drugs to prevent drug-induced liver injury.
药物性肝损伤是急性肝损伤的主要原因,随着新药数量的增加,药物性肝损伤的发生率似乎也在增加。2004 年日本消化疾病周国际共识会议对药物性肝损伤的诊断标准进行了修订,包括药物淋巴细胞刺激试验和嗜酸性粒细胞评分。虽然改良的诊断标准很有用,并且在日本得到广泛应用,但未来仍有许多问题需要研究。根据最近对日本药物性肝损伤病例的调查,膳食补充剂引起的药物性肝损伤也在增加,这在国外也有观察到。需要更多的研究来阐明各种药物的药物代谢机制和肝损伤的病理生理学,以预防药物性肝损伤。